| Message: | Quick Detail:
1. CAS No.: 863288-34-0
2. Molecular Formula: C165H271N47O46
3. Molecular Weight: 3649.30
4. Purity (HPLC): 98.0%
5. Appearance: White powder
6. Alias: CJC-1295 Acetate; CJC1295(Without DAC);
7. Grade:Pharmaceutical Grade
9. Use: Hormones and Regulation of Endocrine Function of Drug
Description:
CJC-1295 DAC has shown some amazing results as a releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase and IGF-I secretion and its benefits, but it has been able to do so in very large amounts.
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life.
Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days.
Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human .
Application:
CJC-1295 is an injectable peptide used to increase GH production. This peptide is a hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.
The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well.
Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH |
my account
